Literature DB >> 35878875

Mice lacking proSAAS display alterations in emotion, consummatory behavior and circadian entrainment.

Dipendra K Aryal1, Ramona M Rodriguiz1,2, Ngoc Lien Nguyen1, Matthew W Pease1, Daniel J Morgan3, John Pintar4, Lloyd D Fricker5, William C Wetsel2,6,7.   

Abstract

ProSAAS is a neuroendocrine protein that is cleaved by neuropeptide-processing enzymes into more than a dozen products including the bigLEN and PEN peptides, which bind and activate the receptors GPR171 and GPR83, respectively. Previous studies have suggested that proSAAS-derived peptides are involved in physiological functions that include body weight regulation, circadian rhythms and anxiety-like behavior. In the present study, we find that proSAAS knockout mice display robust anxiety-like behaviors in the open field, light-dark emergence and elevated zero maze tests. These mutant mice also show a reduction in cued fear and an impairment in fear-potentiated startle, indicating an important role for proSAAS-derived peptides in emotional behaviors. ProSAAS knockout mice exhibit reduced water consumption and urine production relative to wild-type controls. No differences in food consumption and overall energy expenditure were observed between the genotypes. However, the respiratory exchange ratio was elevated in the mutants during the light portion of the light-dark cycle, indicating decreased fat metabolism during this period. While proSAAS knockout mice show normal circadian patterns of activity, even upon long-term exposure to constant darkness, they were unable to shift their circadian clock upon exposure to a light pulse. Taken together, these results show that proSAAS-derived peptides modulate a wide range of behaviors including emotion, metabolism and the regulation of the circadian clock.
© 2022 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; circadian activity; fear; metabolism; mice; proSAAS knockout

Mesh:

Substances:

Year:  2022        PMID: 35878875      PMCID: PMC9444949          DOI: 10.1111/gbb.12827

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.708


  53 in total

1.  Neuronal circuits for fear and anxiety - the missing link.

Authors:  Richard Apps; Piergiorgio Strata
Journal:  Nat Rev Neurosci       Date:  2015-09-03       Impact factor: 34.870

Review 2.  The neurocircuitry of remote cued fear memory.

Authors:  Hadley C Bergstrom
Journal:  Neurosci Biobehav Rev       Date:  2016-09-28       Impact factor: 8.989

3.  Embryonic gene expression and pro-protein processing of proSAAS during rodent development.

Authors:  Daniel J Morgan; Nino Mzhavia; Bonnie Peng; Hui Pan; Lakshmi A Devi; John E Pintar
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

4.  Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.

Authors:  Andrea L Pappas; Alexandra L Bey; Xiaoming Wang; Mark Rossi; Yong Ho Kim; Haidun Yan; Fiona Porkka; Lara J Duffney; Samantha M Phillips; Xinyu Cao; Jin-Dong Ding; Ramona M Rodriguiz; Henry H Yin; Richard J Weinberg; Ru-Rong Ji; William C Wetsel; Yong-Hui Jiang
Journal:  JCI Insight       Date:  2017-10-19

5.  Intensive design in evaluating anxiolytic agents.

Authors:  E H Uhlenhuth; D A Turner; G Purchatzke; T Gift; J Chassan
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

6.  The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1.

Authors:  Y Qian; L A Devi; N Mzhavia; S Munzer; N G Seidah; L D Fricker
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  Distribution of proSAAS-derived peptides in rat neuroendocrine tissues.

Authors:  Y Feng; S E Reznik; L D Fricker
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Obesity and diabetes in transgenic mice expressing proSAAS.

Authors:  Suwen Wei; Yun Feng; Fa-Yun Che; Hui Pan; Nino Mzhavia; Lakshmi A Devi; Audra A McKinzie; Nancy Levin; William G Richards; Lloyd D Fricker
Journal:  J Endocrinol       Date:  2004-03       Impact factor: 4.286

9.  The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning.

Authors:  Erin N Bobeck; Ivone Gomes; Darlene Pena; Kirstie A Cummings; Roger L Clem; Mihaly Mezei; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2017-04-20       Impact factor: 8.294

10.  The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.

Authors:  Timo D Müller; Anne Müller; Chun-Xia Yi; Kirk M Habegger; Carola W Meyer; Bruce D Gaylinn; Brian Finan; Kristy Heppner; Chitrang Trivedi; Maximilian Bielohuby; William Abplanalp; Franziska Meyer; Carolin L Piechowski; Juliane Pratzka; Kerstin Stemmer; Jenna Holland; Jazzmin Hembree; Nakul Bhardwaj; Christine Raver; Nickki Ottaway; Radha Krishna; Renu Sah; Floyd R Sallee; Stephen C Woods; Diego Perez-Tilve; Martin Bidlingmaier; Michael O Thorner; Heiko Krude; David Smiley; Richard DiMarchi; Susanna Hofmann; Paul T Pfluger; Gunnar Kleinau; Heike Biebermann; Matthias H Tschöp
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.